Aurobindo Pharma has reported total income of Rs.6001.50 crores during the period ended March 31, 2021 as compared to Rs.6364.91 crores during the period ended December 31, 2020. The company reported total income of Rs.6158.43 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.801.58 crores for the period ended March 31, 2021 as against net profit of Rs.2946.46 crores for the period ended December 31, 2020. It posted net profit of Rs.864 crores for the period ended March 31, 2020. 

Aurobindo Pharma has reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021 as compared to Rs.23098.50 crores during the 12 months period ended March 31, 2020. 

The company has posted net profit of Rs.5334.85 crores for the 12 months period ended March 31, 2021 as against net profit of Rs.2845.13 crores for the 12 months period ended March 31, 2020.